The 20 Best Gallbladder Cancer Doctors near Bronx, NY

William Jarnagin is a General Surgeon in New York, New York. Dr. Jarnagin is rated as an Elite provider by MediFind in the treatment of Gallbladder Cancer. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Gallbladder Cancer, Hepatectomy, and Pancreatectomy.

Michael D'angelica is a General Surgeon and a Surgical Oncologist in New York, New York. Dr. D'angelica is rated as an Elite provider by MediFind in the treatment of Gallbladder Cancer. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Colorectal Cancer, Hepatectomy, and Pancreatectomy. Dr. D'angelica is currently accepting new patients.

Ghassan Abou is an Oncologist in New York, New York. Dr. Abou is rated as an Elite provider by MediFind in the treatment of Gallbladder Cancer. His top areas of expertise are Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), Fibrolamellar Carcinoma, Liver Embolization, and Pancreaticoduodenectomy. Dr. Abou is currently accepting new patients.

Ioannis Hatzaras is a Surgical Oncologist in New York, New York. Dr. Hatzaras is rated as an Elite provider by MediFind in the treatment of Gallbladder Cancer. His top areas of expertise are Gallbladder Cancer, Gallbladder Disease, Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Removal, and Lymphadenectomy.

Gulam Manji, M.D., Ph.D. is an Associate Professor of Medicine at Columbia University Medical Center. Dr. Manji received his M.D. degree from Ross University School of Medicine in 2009 and completed his residency in internal medicine at Albany Medical College. He then completed his fellowship in Hematology/Oncology at NewYork-Presbyterian/Columbia, where his clinical focus was on the treatment of gastrointestinal malignancies, melanoma, and sarcoma under the mentorship of Dr. Gary Schwartz, Chief of Hematology and Oncology.Dr. Manji conducts translational research with the overall goal to developing new treatments for cancer. His focus is in gastrointestinal malignancies, particularly pancreas adenocarcinoma, on which he is conducting preclinical combination immunotherapy studies on genetically engineered mice with pancreas cancer in the Olive laboratory at the Herbert Irving Comprehensive Cancer Center. The combination immunotherapy preclinical proposal received the Young Investigator Award from the American Society of Clinical Oncology-2015. The goal of these preclinical studies is to bring promising new therapies to the clinic in an early phase clinical trials Dr. Manji's research career in identifying new genes and their implication in disease has led to numerous key publications and an issued patent.Dr. Manji cares for patients with gastrointestinal malignancies, with a particular focus on pancreatic and liver cancers, and sarcomas. He is the principal investigator of an investigator-initiated multicenter clinical trial that he wrote with Dr. Gary Schwartz in sarcoma and malignant peripheral nerve sheath tumors and is responsible for clinical trials conducted in liver, bile duct, gallbladder, and pancreas cancers at Columbia University Medical Center. Dr. Manji is rated as an Advanced provider by MediFind in the treatment of Gallbladder Cancer. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Malignant Peripheral Nerve Sheath Tumor, and Familial Pancreatic Cancer.

Bahar Laderian, MD, is Director of the Neuroendocrine Tumors Program at Montefiore Einstein Comprehensive Cancer Center and Assistant Professor of Medicine and Oncology at Albert Einstein College of Medicine. Dr. Laderian’s clinical focus is on the treatment of neuroendocrine tumors (carcinoid), adrenocortical carcinoma and carcinomas, pheochromocytomas, paragangliomas, and gastrointestinal cancers including anal cancers, colorectal cancers, cancer of the appendix, intestinal cancers, anal cancers, pancreatic cancers, hepatocellular carcinomas, cholangiocarcinomas and gastroesophageal cancers. Dr. Laderian is rated as an Experienced provider by MediFind in the treatment of Gallbladder Cancer. Her top areas of expertise are Glomus Tympanum Tumor, Glomus Jugulare Tumor, Lynch Syndrome, Gastroesophageal Junction Cancer, and Gamma Knife Radiosurgery.

Chaoyuan Kuang, MD, PhD, is Assistant Professor, Oncology, Medicine and Molecular Pharmacology at Montefiore Einstein and Co-Leader, GI Clinical and Translational Research at Montefiore Einstein Cancer Center. His clinical focus is on the treatment of patients with colorectal and other gastrointestinal malignancies, as well as the enrollment of patients into clinical trials. Dr. Kuang is rated as an Experienced provider by MediFind in the treatment of Gallbladder Cancer. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Pancreatic Cancer.

Peter Hongdau Liu, MD, PhD, is a surgical oncologist and endocrine surgeon at Montefiore Einstein and Assistant Professor, Surgical Oncology at Albert Einstein College of Medicine. Dr. Liu’s clinical focus includes malignant and benign diseases of the pancreas, liver, gallbladder, small bowel and stomach, as well as endocrine diseases, specifically thyroid, parathyroid and adrenal endocrinopathies. . His top areas of expertise are Pancreatic Ductal Adenocarcinoma, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Gastro-Intestinal Cancer. Dr. Kaubisch is rated as an Advanced provider by MediFind in the treatment of Gallbladder Cancer. His top areas of expertise are Liver Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), and Ampullary Cancer.

Sarah Bellemare, MD, FRCS, is an attending physician in surgery and Assistant Professor of Surgery at Montefiore-Einstein. She leads the pancreas cancer tumor board at Montefiore Einstein Center for Cancer Care and is the UNOS Surgical Director of both the Live Donor Liver Transplant and Pediatric Liver Transplant Programs at Montefiore-Einstein. A recognized master surgeon, Dr. Bellemare’s clinical focus is on complex hepatobiliary and pancreatic cancer vascular reconstruction. She is also skilled in minimally invasive cancer surgery and is a core member of the multidisciplinary liver and pancreas cancer teams. Dr. Bellemare is rated as an Experienced provider by MediFind in the treatment of Gallbladder Cancer. Her top areas of expertise are Familial Pancreatic Cancer, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Liver Transplant.

Milan Kinkhabwala, MD, FACS, is Chief, Division of Transplantation Surgery and Professor of Surgery and Medicine at Montefiore Einstein. He is also Director, Hepatobiliary Cancer at Montefiore Einstein Center for Cancer Care and Director, Abdominal Transplantation at Montefiore Einstein Center for Transplantation. He joined the Montefiore team in 2007 to help build the Transplant Center of Excellence, which included the development of a new liver disease program in adults and children. Dr. Kinkhabwala is rated as an Experienced provider by MediFind in the treatment of Gallbladder Cancer. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Liver Cancer, Kidney Transplant, and Liver Transplant.

Rafi Kabarriti, MD, is a cum laude graduate of Columbia University with a bachelor’s degree in biochemistry and economics. Dr. Kabarriti is rated as an Experienced provider by MediFind in the treatment of Gallbladder Cancer. His top areas of expertise are Anal Cancer, Laryngeal Cancer, Throat Cancer, and Cervical Cancer.

John Chabot is an Oncologist in New York, New York. Dr. Chabot is rated as a Distinguished provider by MediFind in the treatment of Gallbladder Cancer. His top areas of expertise are Familial Pancreatic Cancer, Pancreatic Cancer, Pancreatic Adenoma, Pancreatectomy, and Small Bowel Resection. Dr. Chabot is currently accepting new patients.

Dr. Yoanna Pumpalova is an Assistant Professor of Medicine and medical oncologist at Columbia University Irving Medical Center where she specializes in the treatment of gastrointestinal malignancies, with a focus on colorectal and anal cancers. She received her MD from Weill Cornell Medical College and completed internship and residency training in Internal Medicine and Global Health at Stanford University. She then completed fellowship training in Medical Oncology at Columbia University/New York Presbyterian Hospital. Dr. Pumpalova works as part of a multidisciplinary team with the mission of delivering compassionate and state-of-the-art oncologic care to each patient, using a precision medicine approach to provide innovative and promising treatments.Dr. Pumpalova is actively involved in translational research to understand the biological mechanisms driving early onset colorectal cancer. She collaborates with Dr. Joel Gabre, a gastroenterologist and clinician scientist and Dr. Beatrice Dionigi, colorectal surgeon, on research to understand how early onset colorectal cancer differs from average onset colorectal cancer, with the goal of uncovering novel ways to treat all patients with colorectal cancer. Dr. Pumpalova is also the site principal investigator of industry-sponsored clinical trials investigating novel therapies for the treatment of colorectal cancer. Further, Dr. Pumpalova conducts studies in low- and middle-income countries focused on early detection and screening for colorectal cancer. She has active studies in South Africa and Dominican Republic. Her research goal is to improve outcomes for patients diagnosed with colorectal cancer, regardless of where they reside. Her work has been recognized by several awards including an ASCO Young Investigator Award and ASCO Career Development Award.In the NewsColumbia Researchers Seek Answers for Rise of Colon Cancer in Younger PatientsWhat to Know About the Rise of Colorectal Cancer in Younger PeopleExploring Strategies for Earlier Colon Cancer Detection in Sub-Saharan Africa. Dr. Pumpalova is rated as an Experienced provider by MediFind in the treatment of Gallbladder Cancer. Her top areas of expertise are Colorectal Cancer, Anal Cancer, Familial Colorectal Cancer, Colonoscopy, and Endoscopy.

Tarek Elrafei is an Oncologist in Bronx, New York. Dr. Elrafei is rated as an Experienced provider by MediFind in the treatment of Gallbladder Cancer. His top areas of expertise are Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Breast Cancer, Bone Marrow Aspiration, and Thrombectomy.

Susan Bates is an Internal Medicine specialist and an Oncologist in New York, New York. Dr. Bates is rated as an Advanced provider by MediFind in the treatment of Gallbladder Cancer. Her top areas of expertise are Pancreatic Cancer, T-Cell Lymphoma, Pancreatic Ductal Adenocarcinoma, and Cutaneous T-Cell Lymphoma (CTCL). Dr. Bates is currently accepting new patients.

Paresh Shah is a General Surgeon in New York, New York. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Gallbladder Cancer. His top areas of expertise are Gastrointestinal Stromal Tumor, Familial Pancreatic Cancer, Neuroendocrine Tumor, Small Bowel Resection, and Pancreatectomy.

Vladimir Moliver is a primary care provider, practicing in Family Medicine in New York, New York. Dr. Moliver is rated as an Advanced provider by MediFind in the treatment of Gallbladder Cancer. His top areas of expertise are Gallbladder Adenocarcinoma, Gallbladder Cancer, Anemia, and Vitamin D Deficiency.

David Horowitz, M.D. is a board-certified radiation oncologist and Associate Professor of Radiation Oncology at New York-Presbyterian/Columbia University Irving Medical Center. His clinical focus is on gastrointestinal cancers, lymphoma and breast cancer, and his research interests focus on the development of novel ways to deliver precision radiation therapy to hard-to-treat cancers. Dr. Horowitz received his B.A. from Dartmouth College and his M.D. from the Johns Hopkins University School of Medicine, during which time he completed a research fellowship in the Department of Radiation Oncology and Molecular Radiation Sciences. He completed his internal medicine internship training at the Georgetown University/Washington Hospital Center after which he completed his radiation oncology training at New York Presbyterian Hospital (Columbia University Medical Center Campus), where he additionally served as Chief Resident.Dr. Horowitz has developed the use of multiple radiation techniques at the Columbia University Irving Medical Center to best help patients with cancer receive the most effective treatments while minimizing potential side effects. These include stereotactic body radiation therapy (SBRT), stereotactic radiosurgery, hypofractionated ablative radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy, intraoperative radiotherapy, brachytherapy, total body irradiation, and total skin electron beam therapy. As a member of the Pancreas Center at Columbia, Dr. Horowitz is part of a multidisciplinary team that brings expertise from multiple specialties, including surgery, medical oncology and radiology to the care of complex patients with pancreas cancer.Outside of his clinical duties, Dr. Horowitz serves as Director of Medical Student Education in the Department of Radiation Oncology, as well as the Associate Program Director for the department's residency program. Dr. Horowitz has mentored numerous medical students and residents, with multiple mentees receiving competitive research grants from the NIH, American Medical Association, and Gold Foundation. For a list of publications, please visit Pubmed.gov. Dr. Horowitz is rated as an Experienced provider by MediFind in the treatment of Gallbladder Cancer. His top areas of expertise are Familial Pancreatic Cancer, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), and Breast Cancer.

Lisa A. Kachnic, MD, one of the nation’s leading radiation oncologists and a pioneer of new approaches to optimize the effectiveness of radiation therapy, is the Chu H. Chang Professor and Chief of the Department of Radiation Oncology at Columbia University Vagelos College of Physicians and Surgeons (VP&S) and Chief of the Radiation Oncology Service at NewYork-Presbyterian/Columbia University Irving Medical Center (CUIMC). She also serves as Associate Director of Radiation Oncology and Science in the Herbert Irving Comprehensive Cancer Center (HICCC). Dr. Kachnic’s combined focus on clinical excellence, technological innovation, and patient-centered research continues to advance the field of radiation oncology, which has resulted in over 150 publications and over $17 million in research support from major federal and non-profit agencies. She is widely recognized for gastrointestinal research that has transformed the standard of care for several cancers by integrating novel radiation delivery techniques. A past president of the American Board of Radiology, Dr. Kachnic is internationally known for her clinical trial leadership positions in the National Cancer Institute and its cooperative group research bases. She currently serves as Vice Chair of the Radiation Oncology Committee and Co-Chair of the Ano-Rectal Subcommittee for the SWOG Cancer Research Network research base, for which she is the multi-modality executive officer, as well as NRG Oncology’s Associate PI of their NCORP (NCI Community Oncology Research Program) and chair of the NCORP’s Cancer Control Committee. At Columbia, she is contact PI of Columbia’s NCORP and is co-PI of several NCI training grants for residents and early career faculty. Dr. Kachnic is rated as an Experienced provider by MediFind in the treatment of Gallbladder Cancer. Her top areas of expertise are Anal Cancer, Anaplastic Large Cell Lymphoma, T-Cell Lymphoma, and Pancreatic Cancer.